• What is Platelet Rich Plasma?

    What is Platelet Rich Plasma?

    My team dedicates an inordinate amount of time answering questions and attempting to clarify the misunderstanding of patients when it comes to Platelet Rich Plasma; actually, the entire subspecialty of “Stem Cell Therapy” but let’s start with PRP. As an orthopedic surgeon who introduced Cellular...

    Read More

  • FDA Compliant Therapies

    For those who may have missed it, I was featured Monday night in a Fox 32 news report presented by Fox News investigative reporter Sylvia Perez. http://www.fox32chicago.com/health/customers-warn-that-doctors-are-scamming-patients-with-fake-stem-cell-claims Regular readers of my Blog are aware of the...

    Read More

  • Cellular Orthopedics, looking back and looking forward

    Cellular Orthopedics, looking back and looking forward

    Or as Dan Brown’s Origin explores, “Where did we come from, where are we going?” It seems customary to make predictions at this time of year; but I want to begin by looking back four decades. It is more than reminiscence. Until managed health care was introduced into the marketplace...

    Read More

  • “Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-based Products: Minimal Manipulation and Homologous Use”

    On November 16, 2017, The FDA posted definitive guidelines concerning what meets minimal manipulation rules and regulations and what is accepted under the practice of medicine guidelines in the specialty of Regenerative Medicine. The FDA further restated the requirement that regenerative medicine be...

    Read More

  • My Algorithm If Stem Cell Intervention Doesn’t Last or Doesn’t Work

    My Algorithm If Stem Cell Intervention Doesn’t Last or Doesn’t Work

    I am being forthright; based on my review of data, while 80% or more of my patients continue to enjoy satisfactory outcomes at four years or more following a stem cell intervention, there are those whose symptoms and functional limitations recur. Please be aware that when I undertake the care and treatment...

    Read More

  • Vanity, Anecdote and Evidence; how far I will go to present the facts

    As regular readers of this Blog are aware and as well, those patients who seek consultation in my office, my cellular orthopedics practice is based on clinical evidence. While the largest marketer of stem cells in the Midwest, bases a recommendation for a product without scientific evidence or even anecdote,...

    Read More

  • Ongoing happenings in Stem Cell Care of Arthritis

    Ongoing happenings in Stem Cell Care of Arthritis

    The number of options for regenerative medicine continues to multiply in metropolitan Chicago so the patient seeking the best alternative must remain ever vigilant. A two-day course basically allows anyone with a medical license to become an immediate “expert”. Incidentally, several of these national...

    Read More

  • Postpone, perhaps avoid joint replacements

    Postpone, perhaps avoid joint replacements

    Last week, we traveled to Israel to celebrate the wedding of our youngest son. Israel became the destination for the event as Eric and Judith had met there while his music business was subcontracting to Coke and Judith led the International Marketing initiatives for Coke. The event took place on July...

    Read More

  • Regenerative options for patients receiving chemotherapy, immunosuppression or radiation therapy

    Regenerative options for patients receiving chemotherapy, immunosuppression or radiation therapy

    There has always been a category of patients for whom Bone Marrow Concentrate derived stem cells and growth factors were not a viable option. Patients who have received or are receiving chemotherapy, radiation therapy or immunosuppression have diminished stem cell viability and actual numbers. Such...

    Read More

  • Report from the OrthoBiologic Institute meeting, June 08-10, 2017

    Report from the OrthoBiologic Institute meeting, June 08-10, 2017

    It was difficult for me to sit and listen to so many “show and tell” presentations not supported by scientifically overseen outcomes data. Too much anecdote about unproven methodologies; many not compliant with FDA guidance. Basically, it was frequently repeated false news. I was taken aback by what...

    Read More

Back to top